Swiss Biotech Launches Amidst Hot Streak for Rare Autoimmune Disease
Swiss biotech Chord Therapeutics launched this week with a €13.7M Series A, becoming the latest…
Keep up to date with the latest advances in medical biotechnology and discover how biotech is transforming and improving the way we treat disease.
Swiss biotech Chord Therapeutics launched this week with a €13.7M Series A, becoming the latest…
The recent EU and Japan approvals of the rheumatoid arthritis drug filgotinib contrast with the…
Since Germany legalized cannabis for medical use in 2017, we have frequently spoken to Peter…
Roche’s acquisition of the Irish biotech Inflazome is a vote of confidence for emerging inflammatory…
3D printing has revolutionized manufacturing by reducing costs and giving designers and engineers immense flexibility.…
As a wave of Covid-19 infected the crew of a commercial fishing vessel, three sailors…
The crisis of antibiotic resistance is making the discovery and development of new antibiotics crucial,…
After years of drought, recent technological and clinical breakthroughs are causing research into chronic kidney…
The first generation of vaccines for Covid-19 is edging closer to the market. But are…
A drug developed by the US firm Unity Biotechnology -- designed to slow the aging…
Despite the recent EU approval of the first hepatitis D treatment, low public awareness remains…
The share price of CureVac has skyrocketed almost fivefold after the Covid-19 vaccine developer priced…